242 related articles for article (PubMed ID: 12110166)
21. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.
Rizzo G; Disante M; Mencarelli A; Renga B; Gioiello A; Pellicciari R; Fiorucci S
Mol Pharmacol; 2006 Oct; 70(4):1164-73. PubMed ID: 16778009
[TBL] [Abstract][Full Text] [Related]
22. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
[TBL] [Abstract][Full Text] [Related]
23. An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by phosphatidylinositol 3-kinase.
Fernández de Mattos S; Lam EW; Tauler A
Biochem J; 2002 Nov; 368(Pt 1):283-91. PubMed ID: 12139485
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia.
Yun Z; Maecker HL; Johnson RS; Giaccia AJ
Dev Cell; 2002 Mar; 2(3):331-41. PubMed ID: 11879638
[TBL] [Abstract][Full Text] [Related]
25. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.
Müller H; Bracken AP; Vernell R; Moroni MC; Christians F; Grassilli E; Prosperini E; Vigo E; Oliner JD; Helin K
Genes Dev; 2001 Feb; 15(3):267-85. PubMed ID: 11159908
[TBL] [Abstract][Full Text] [Related]
26. Changes in E2F DNA-binding activity during induced erythroid differentiation.
Richon VM; Venta-Perez G
Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031
[TBL] [Abstract][Full Text] [Related]
27. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
28. Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor.
Yoshida K; Inoue I
Oncogene; 2004 Aug; 23(37):6250-60. PubMed ID: 15195143
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the G1/S transition phase in mesangial cells by E2F1.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Oct; 56(4):1238-41. PubMed ID: 10504464
[TBL] [Abstract][Full Text] [Related]
30. Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.
Croxton R; Ma Y; Cress WD
Oncogene; 2002 Feb; 21(10):1563-70. PubMed ID: 11896585
[TBL] [Abstract][Full Text] [Related]
31. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.
Forman BM; Tontonoz P; Chen J; Brun RP; Spiegelman BM; Evans RM
Cell; 1995 Dec; 83(5):803-12. PubMed ID: 8521497
[TBL] [Abstract][Full Text] [Related]
32. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
33. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
Halaban R; Cheng E; Smicun Y; Germino J
J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
[TBL] [Abstract][Full Text] [Related]
34. [Differences in human and rat FSH receptors promote activity as a result of the transcriptional factors: E2F1, E2F4 and E2F5 overexpression].
Putowski L; Gasior W; Gogacz M; Gagała J; Jakowicki JA
Ginekol Pol; 2001 Dec; 72(12A):1560-6. PubMed ID: 11883315
[TBL] [Abstract][Full Text] [Related]
35. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW
Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of E2F transcription factors in chemically induced mouse skin tumors.
Balasubramanian S; Ahmad N; Mukhtar H
Int J Oncol; 1999 Aug; 15(2):387-90. PubMed ID: 10402252
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
39. Myc requires distinct E2F activities to induce S phase and apoptosis.
Leone G; Sears R; Huang E; Rempel R; Nuckolls F; Park CH; Giangrande P; Wu L; Saavedra HI; Field SJ; Thompson MA; Yang H; Fujiwara Y; Greenberg ME; Orkin S; Smith C; Nevins JR
Mol Cell; 2001 Jul; 8(1):105-13. PubMed ID: 11511364
[TBL] [Abstract][Full Text] [Related]
40. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.
Saavedra HI; Wu L; de Bruin A; Timmers C; Rosol TJ; Weinstein M; Robinson ML; Leone G
Cell Growth Differ; 2002 May; 13(5):215-25. PubMed ID: 12065245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
